Baeuerle Patrick 4
4 · Harpoon Therapeutics, Inc. · Filed Jun 1, 2020
Insider Transaction Report
Form 4
Baeuerle Patrick
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2020-05-28+2,584→ 2,584 totalExercise: $20.59Exp: 2030-05-27→ Common Stock (2,584 underlying) - Award
Director Stock Option (Right to Buy)
2020-05-28+10,167→ 10,167 totalExercise: $20.59Exp: 2030-05-27→ Common Stock (10,167 underlying)
Footnotes (2)
- [F1]The stock option will fully vest and become exercisable on May 28, 2021, subject to the continuous service of the Reporting Person with the Issuer on such date.
- [F2]The stock option vests and becomes exercisable as to 25% of the shares subject to the option on the last day of each calendar quarter following the grant date of May 28, 2020 (on June 30, 2020, September 30, 2020, December 31, 2020, and March 31, 2021), subject to the continuous service of the Reporting Person on each vesting date.